Search Results - "Reed, Steven"

Refine Results
  1. 1

    Key roles of adjuvants in modern vaccines by Reed, Steven G, Orr, Mark T, Fox, Christopher B

    Published in Nature medicine (01-12-2013)
    “…Adjuvants play an important part in vaccines, as they can enhance and shape antigen-specific immune responses. This Review discusses the benefits of adjuvants…”
    Get full text
    Journal Article
  2. 2

    A synthetic adjuvant to enhance and expand immune responses to influenza vaccines by Coler, Rhea N, Baldwin, Susan L, Shaverdian, Narek, Bertholet, Sylvie, Reed, Steven J, Raman, Vanitha S, Lu, Xiuhua, DeVos, Joshua, Hancock, Kathy, Katz, Jacqueline M, Vedvick, Thomas S, Duthie, Malcolm S, Clegg, Christopher H, Van Hoeven, Neal, Reed, Steven G

    Published in PloS one (27-10-2010)
    “…Safe, effective adjuvants that enhance vaccine potency, including induction of neutralizing Abs against a broad range of variant strains, is an important…”
    Get full text
    Journal Article
  3. 3

    Ubiquitin ligases and cell cycle control by Teixeira, Leonardo K, Reed, Steven I

    Published in Annual review of biochemistry (01-01-2013)
    “…The ubiquitin-proteasome system plays a pivotal role in the sequence of events leading to cell division known as the cell cycle. Not only does…”
    Get full text
    Journal Article
  4. 4

    Make it a combo by Reed, Steven G, Carter, Darrick

    Published in Science translational medicine (31-07-2024)
    “…Adjuvants that combine TLR agonists and inflammatory agonists promote robust and durable vaccine responses (Bechtold . and Arunachalam .)…”
    Get more information
    Journal Article
  5. 5

    Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant by Coler, Rhea N, Bertholet, Sylvie, Moutaftsi, Magdalini, Guderian, Jeff A, Windish, Hillarie Plessner, Baldwin, Susan L, Laughlin, Elsa M, Duthie, Malcolm S, Fox, Christopher B, Carter, Darrick, Friede, Martin, Vedvick, Thomas S, Reed, Steven G

    Published in PloS one (26-01-2011)
    “…Innate immune responses to vaccine adjuvants based on lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls, are driven by Toll-like…”
    Get full text
    Journal Article
  6. 6

    Use of defined TLR ligands as adjuvants within human vaccines by Duthie, Malcolm S., Windish, Hillarie Plessner, Fox, Christopher B., Reed, Steven G.

    Published in Immunological reviews (01-01-2011)
    “…Our improved understanding of how innate immune responses can be initiated and how they can shape adaptive B‐ and T‐cell responses is having a significant…”
    Get full text
    Journal Article
  7. 7

    New horizons in adjuvants for vaccine development by Reed, Steven G, Tomai, Mark, Gale, Michael J

    Published in Current opinion in immunology (01-08-2020)
    “…Adjuvant molecules, particularly toll like receptor (TLR) agonists have been in development for decades, though until now only a natural TLR 4 ligand…”
    Get full text
    Journal Article
  8. 8

    Adjuvants for human vaccines by Alving, Carl R, Peachman, Kristina K, Rao, Mangala, Reed, Steven G

    Published in Current opinion in immunology (01-06-2012)
    “…Highlights ► Formulations of adjuvants can have different properties than individual adjuvants. ► Beneficial adjuvant formulations can be made with alum, oil…”
    Get full text
    Journal Article
  9. 9

    Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment by Hossain, Faria, Ghosh, Prakash, Khan, Md Anik Ashfaq, Duthie, Malcolm S, Vallur, Aarthy C, Picone, Alessandro, Howard, Randall F, Reed, Steven G, Mondal, Dinesh

    Published in PloS one (28-09-2017)
    “…Sustained elimination of Visceral Leishmaniasis (VL) requires the reduction and control of parasite reservoirs to minimize the transmission of Leishmania…”
    Get full text
    Journal Article
  10. 10

    Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL‐18, and IFN‐γ by Desbien, Anthony L., Reed, Steven J., Bailor, Hilton R., Cauwelaert, Natasha Dubois, Laurance, John D., Orr, Mark T., Fox, Christopher B., Carter, Darrick, Reed, Steven G., Duthie, Malcolm S.

    Published in European journal of immunology (01-02-2015)
    “…The synthetic TLR4 agonist glucopyranosyl lipid adjuvant (GLA) is a potent Th1‐response‐inducing adjuvant when formulated in a squalene oil‐in‐water emulsion…”
    Get full text
    Journal Article
  11. 11

    Adjuvants for cancer vaccines by Dubensky, Thomas W, Reed, Steven G

    Published in Seminars in immunology (01-06-2010)
    “…Abstract The recent FDA approval of sipuleucel-T (Provenge® ), a patient-specific immunotherapy for androgen-independent prostate cancer developed by Dendreon…”
    Get full text
    Journal Article
  12. 12

    New horizons in adjuvants for vaccine development by Reed, Steven G, Bertholet, Sylvie, Coler, Rhea N, Friede, Martin

    Published in Trends in immunology (01-01-2009)
    “…Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now in licensed products or in late stage…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants by Desbien, Anthony L, Dubois Cauwelaert, Natasha, Reed, Steven J, Bailor, Hilton R, Liang, Hong, Carter, Darrick, Duthie, Malcolm S, Fox, Christopher B, Reed, Steven G, Orr, Mark T

    Published in The Journal of immunology (1950) (01-12-2016)
    “…Designing modern vaccine adjuvants depends on understanding the cellular and molecular events that connect innate and adaptive immune responses. The synthetic…”
    Get full text
    Journal Article
  16. 16

    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model by Baldwin, Susan L, Reese, Valerie A, Larsen, Sasha E, Beebe, Elyse, Guderian, Jeff, Orr, Mark T, Fox, Christopher B, Reed, Steven G, Coler, Rhea N

    Published in PloS one (11-03-2021)
    “…An estimated 10 million people developed tuberculosis (TB) disease in 2019 which underscores the need for a vaccine that prevents disease and reduces…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Patronage and Predominance: How the LDP Maintains Its Hold on Power by REED, Steven R

    Published in Social science Japan journal (05-02-2022)
    “…Abstract The Liberal Democratic Party (LDP) held power from 1955 until 1993. How did it manage to do so? In 1994 a political reform resulted in competitive…”
    Get full text
    Journal Article
  19. 19

    Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases by Duthie, Malcolm S., Reed, Steven G.

    “…Immunological and molecular advances have modernized diagnostic testing for many diseases. Although interferon gamma-release and polymerase chain reaction…”
    Get full text
    Journal Article
  20. 20

    Cyclin E Deregulation Promotes Loss of Specific Genomic Regions by Teixeira, Leonardo K., Wang, Xianlong, Li, Yongjiang, Ekholm-Reed, Susanna, Wu, Xiaohua, Wang, Pei, Reed, Steven I.

    Published in Current biology (18-05-2015)
    “…Cell-cycle progression is regulated by the cyclin-dependent kinase (Cdk) family of protein kinases, so named because their activation depends on association…”
    Get full text
    Journal Article